Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ CBD
CBD
24 registered clinical trials studyying CBD —
4 currently recruiting
.
Status
Trial
Sponsor
Phase
Recruiting
Effects of Cannabidiol on Stress and Nicotine Withdrawal
NCT07001930
Johns Hopkins University
Phase 1
Recruiting
Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
NCT07069478
University of Minnesota
N/A
Active Not Recruiting
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
NCT05956834
Massachusetts General Hospital
—
Unknown
CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)
NCT05562635
Medical University of Silesia
Phase 2 / Phase 3
Completed
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
NCT05490511
Indiana University
Phase 1
Withdrawn
The Use of Cannabinoid Patch for Knee Osteoarthritis
NCT04412837
Northwell Health
Phase 2
Completed
Sex Differences in Neural Response to Cannabidiol
NCT04777643
Yale University
EARLY_Phase 1
Active Not Recruiting
RCT of CBD for Anxiety in Advanced Breast Cancer
NCT04482244
Dana-Farber Cancer Institute
Phase 2
Active Not Recruiting
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
NCT04778644
Hartford Hospital
Phase 1 / Phase 2
Completed
A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy A
NCT05121506
Gefion Canada Inc.
Phase 1
Completed
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
NCT04976738
Cymra Life Sciences
Phase 1 / Phase 2
Unknown
The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Man
NCT04729244
Advanced Pain and Rehab Specialists
Phase 1
Unknown
Effects of Cannabidiol (CBD) on the Brain
NCT04831294
Auburn University
N/A
Unknown
EMERALD TRIAL Open Label Extension Study
NCT04997954
Gold Coast Hospital and Health Service
Phase 4
Recruiting
CBD-Microglia PET Study
NCT04398719
Yale University
EARLY_Phase 1
Unknown
Synthetic CBD as a Therapy for COVID-19
NCT04686539
Sheba Medical Center
Phase 1
Unknown
Methodology for Developing an Occlusal Appliance With CBD Active Carrier
NCT04775030
Medical University of Silesia
Phase 2 / Phase 3
Terminated
Cannabidiol and Management of Endometriosis Pain
NCT04527003
Milton S. Hershey Medical Center
Phase 3
Completed
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
NCT04360044
University of California, San Diego
Phase 2
Enrolling By Invitation
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT04680130
Mayo Clinic
—
Completed
Is Topical CBD Effective in Treating Thumb Joint Arthritis
NCT04611347
University of Virginia
Phase 2
Completed
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
NCT04423341
Silkiss Eye Surgery
Phase 2 / Phase 3
Unknown
Cannabidiol, Morphine, Pain
NCT04030442
Wayne State University
Phase 1
Completed
Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
NCT04851392
University College, London
N/A